We determined if silencing MRP2 by siRNA could increase oxaliplatin accumulation and cytotoxicity in these human CRC and pancreatic cancer cell lines (i.e., Caco-2 and PANC-1). Here, ABCC2 is linked to pancreatic neoplasm.